Calamos Advisors
JNJ icon

Calamos Advisors’s Johnson & Johnson JNJ Stock Holding History

Calamos Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-302,000
Closed -$40M – 637
2017
Q2 		$40M Buy
+302,000
New +$38.5M 0.3% 89

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Calamos Advisors's JNJ Position: Q1 2026 in Review

Calamos Advisors increased its Johnson & Johnson (JNJ) stake by 19% in Q1 2026, buying an estimated $28.5M and bringing the position to 773,100 shares worth $189M. The position accounts for 0.67% of the portfolio, ranked #21.

Calamos Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $237M in Q3 2018. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Calamos Advisors held 773,100 shares of Johnson & Johnson worth $189M as of Q1 2026.
  • Calamos Advisors bought 122,350 Johnson & Johnson shares in Q1 2026, an estimated $28.5M.
  • Johnson & Johnson made up 0.67% of Calamos Advisors's portfolio in Q1 2026, its #21 holding.
  • Calamos Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Calamos Advisors's Johnson & Johnson position peaked at $237M in Q3 2018.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.